Oral Solid Dosage CDMO Market Forecast Report 2033 by Size, Revenue, Business Growth and Demand
The global oral solid dosage (OSD) CDMO market size was estimated at USD 46.37 billion in 2025 and is projected to reach USD 77.06 billion by 2033, expanding at a CAGR of 6.58% from 2026 to 2033. The market’s growth is primarily fueled by the increasing need for cost-efficient and time-effective drug development processes, prompting pharmaceutical and biotechnology companies to outsource more extensively to CDMOs. Rising consumption of tablets and capsules especially for chronic and lifestyle-related conditions further amplifies demand, as these forms offer ease of administration, accurate dosing, and strong patient compliance. Additional key growth drivers include the expansion of generic drug production, patent expiries that pave the way for new entrants, and the growing need for flexible and scalable manufacturing capacities. CDMOs have become essential partners, providing advanced formulation expertise, efficient production scale-up capabilities, and robust reg...